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To the Editor: We read with great interest the recent article by Okogbule-Wonodi et al.
(1) about whether Ureaplasma respiratory tract colonization of preterm infants Ͻ33 wk gestation is associated with an increased risk for necrotizing enterocolitis (NEC). The authors evaluated 368 infants Ͻ33 wk gestation with one or more tracheal or nasopharyngeal aspirates for Ureaplasma culture and PCR obtained during the first week of life. They stated that NEC was confirmed in 29 of 368 (7.9%) of the combined cohorts, and the incidence of NEC was 2.2-fold higher in Ureaplasma-positive (12.3%) than Ureaplasma-negative (5.5%) infants Ͻ33 wk and 3.3-fold higher in Ureaplasmapositive (14.6%) than Ureaplasma-negative (4.4%) infants Յ28 wk. In addition, cord serum IL-6 and IL-1␤ concentrations were significantly higher in Ureaplasma-positive than in Ureaplasmanegative NEC-affected infants, and so, the authors suggested that Ureaplasma may be a factor in NEC pathogenesis in preterm infants by contributing to intestinal mucosal injury and/or altering systemic or local immune responses.
We have recently completed a study concerning effects of Ureaplasma respiratory tract colonization and its management on development of chronic lung disease (unpublished data). When we evaluated 224 enrolled infants who were Ͻ32 wk and seeked for Ureaplasma respiratory colonization with one or more tracheal or nasopharyngeal aspirates for Ureaplasma culture, we could not demonstrate any relationship between Ureaplasma colonization and NEC development (Table 1) , which is similar to previous published study by Perzigian et al. (2) . Two important factors, which were associated with NEC stage Ն2 development, were late-onset proven sepsis, volume of red blood cell transfusion, and cord serum IL-6 (Table 1) . Multivariate logistic regression analysis revealed that there was only significant association between the red blood cell transfusion and NEC development (OR, 1.4; 95% CI, 1.18 -1.74; p ϭ 0.01). Although our results shows similarity with study by Okogbule-Wonodi et al. (1) in high cord serum IL-6 levels and we agree with authors on its possible association with NEC development, it is obvious that authors did not investigate the relationship between red cell transfusion and NEC development. We know that in addition to our results, some recent trials demonstrated the impressive association between transfusion and NEC development (3, 4) , and we suggest that Okogbule-Wonodi et al. (1) 
The pathogenesis of NEC remains poorly understood. Although prematurity is the greatest risk factor for developing NEC, epidemiological studies suggest a multifactorial etiology (1,2). Intestinal immaturity heralded by abnormal microbial intestinal colonization, alterations in intestinal blood flow, and a highly immunoreactive intestinal mucosa are important predisposing factors to the extensive mucosal damage seen in NEC. Contrary to our findings, Ozdemir et al. did not find an association between Ureaplasma colonization and NEC stage Ն2 in their cohort. Several factors may explain the differences in these findings. Our sample size was larger than both the authors' and the Perzigian cohorts (3). We analyzed data from 368 subjects, and NEC incidence remained greater in Ureaplasma colonized compared with negative infants even when substratified to only include infants Յ28 wk gestation at birth. Because culture methodology details were not provided by Ozdemir et al., we cannot comment on whether differences in Ureaplasma detection may have contributed to differences in study outcomes. Although the majority of subjects in our sample were of African-American descent, it is not clear whether the authors included race in their descriptive variables. The incidence of NEC is known to be higher in the African-American population in the United States which is attributed to the higher rate of preterm delivery in African-Americans (4).
Several retrospective studies including the one by the authors have shown a possible association between the timing of packed red blood cell transfusions and the subsequent development of NEC (5). Other recent reports do not define a clear relationship (6). It is therefore difficult to conclusively state causality. Transfusion of the anemic preterm infant has been suggested to cause a reperfusion-type injury to an already compromised immature intestinal mucosa (7). Ingestion of Ureaplasmainfected amniotic fluid by the fetus could potentially initiate an excessive systemic and local intestinal inflammatory response and thus predispose these very LBW infants to NEC. Anemia-related tissue hypoxia may also play a role (8). Although we appreciate the comments of Ozdemir et al., the results from our predominantly African-American sample indicates that a reevaluation of our data along their suggested lines would be of no additional value to our study. 
